Evidence map›Paper›PMID 24269767›Full record

ArticleImmunology letters

Localization of non-linear neutralizing B cell epitopes on ricin toxin's enzymatic subunit (RTA).

Joanne M O'Hara, Jane C Kasten-Jolly, Claire E Reynolds, Nicholas J Mantis

Abstract read
In one paragraph

Article in Immunology letters. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Recent advances in the development of vaccines against ricin.Human vaccines & immunotherapeutics · 2016
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Joanne M O'HaraDivision of Infectious Disease, Wadsworth Center, New York State Department of Health, Albany, NY 12208, United States; Department of Biomedical Sciences, University at Albany School of Public Health, Albany, NY 12201, United States.
Jane C Kasten-JollyDivision of Infectious Disease, Wadsworth Center, New York State Department of Health, Albany, NY 12208, United States.
Claire E ReynoldsDivision of Infectious Disease, Wadsworth Center, New York State Department of Health, Albany, NY 12208, United States.
Nicholas J MantisDivision of Infectious Disease, Wadsworth Center, New York State Department of Health, Albany, NY 12208, United States; Department of Biomedical Sciences, University at Albany School of Public Health, Albany, NY 12201, United States. Electronic address: nmantis@wadsworth.org.
New York State Department of Health · USWadsworth Center · US

Funding

Ricin toxin: Neutralizing antibodies and vaccine designR03AI097688 · NIAID · WADSWORTH CENTER · PI MANTIS, NICHOLAS J. · 2012 to 2013
$136k
NIAID NIH HHS AI097688NIAID NIH HHS R03 AI097688
6 · The paper itself

Abstract

Efforts to develop a vaccine for ricin toxin are focused on identifying highly immunogenic, safe, and thermostable recombinant derivatives of ricin's enzymatic A subunit (RTA). As a means to guide vaccine design, we have embarked on an effort to generate a comprehensive neutralizing and non-neutralizing B cell epitope map of RTA. In a series of previous studies, we identified three spatially distinct linear (continuous), neutralizing epitopes on RTA, as defined by monoclonal antibodies (mAbs) PB10 (and R70), SyH7, and GD12. In this report we now describe a new collection of 19 toxin-neutralizing mAbs that bind non-linear epitopes on RTA. The most potent toxin-neutralizing mAbs in this new collection, namely WECB2, TB12, PA1, PH12 and IB2 each had nanamolar (or sub-nanomolar) affinities for ricin and were each capable of passively protecting mice against a 5-10xLD50 toxin challenge. Competitive binding assays by surface plasmon resonance revealed that WECB2 binds an epitope that overlaps with PB10 and R70; TB12, PA1, PH12 recognize epitope(s) close to or overlapping with SyH7's epitope; and GD12 and IB2 recognize epitopes that are spatially distinct from all other toxin-neutralizing mAbs. We estimate that we have now accounted for ∼75% of the predicted epitopes on the surface of RTA and that toxin-neutralizing mAbs are directed against a very limited number of these epitopes. Having this information provides a framework for further refinement of RTA mutagenesis and vaccine design.

Indexed as

AnimalsAntibodies, BlockingB-LymphocytesCatalytic DomainEpitope MappingEpitopes, B-LymphocyteFemaleHemorrhageHumansHybridomasMiceMice, Inbred BALB CMolecular StructureRicinVaccinesAntibodies, BlockingEpitopes, B-LymphocyteRicinVaccinesAntibodyEpitopeToxinVaccine

Identifiers

PMID24269767
PMCPMC4070743
OpenAlexW2070991929

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.